Copyright
©2009 The WJG Press and Baishideng.
World J Gastroenterol. Jun 7, 2009; 15(21): 2628-2631
Published online Jun 7, 2009. doi: 10.3748/wjg.15.2628
Published online Jun 7, 2009. doi: 10.3748/wjg.15.2628
Demographic characteristics | n | Breath test at screening | |
Positive (n = 54) | Negative (n = 43) | ||
Sex (M/F, mean ± SD) | 40/57 (40.7 ± 16.2) | ||
IBS variants n (%) | |||
Chronic diarrhoea | 31 (31.9) | 19 (35.2) | 12 (27.9) |
Stipsis | 20 (20.6) | 11 (20.4) | 9 (20.9) |
Alternated stipsis/diarrhoea | 46 (47.5) | 24 (44.4) | 22 (51.2) |
Symptoms score | |||
Chronic diarrhoea | 2.2 ± 0.8 | 2.2 ± 0.7 | 2.1 ± 0.6 |
Stipsis | 2.3 ± 0.9 | 2.4 ± 0.8 | 2.1 ± 0.9 |
Alternated stipsis/diarrhoea | 2.0 ± 1.2 | 2.3 ± 0.9 | 1.7 ± 0.6a |
- Citation: Peralta S, Cottone C, Doveri T, Almasio PL, Craxi A. Small intestine bacterial overgrowth and irritable bowel syndrome-related symptoms: Experience with Rifaximin. World J Gastroenterol 2009; 15(21): 2628-2631
- URL: https://www.wjgnet.com/1007-9327/full/v15/i21/2628.htm
- DOI: https://dx.doi.org/10.3748/wjg.15.2628